COMMENT ON A RANDOMIZED CONTROLLED TRIAL OF INTRAVENOUS HALOPERIDOL VERSUS INTRAVENOUS METOCLOPRAMIDE FOR ACUTE MIGRAINE THERAPY IN THE EMERGENCY DEPARTMENT

被引：0

作者：

Fisher, Harold ^{[1
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

来源：

JOURNAL OF EMERGENCY MEDICINE | 2017年 / 52卷 / 03期

关键词：

D O I：

10.1016/j.jemermed.2016.03.041

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

收藏

页码：E75 / E75

页数：1

相关论文

共 2 条

[1]

Fisher Harold, 1995, Journal of Emergency Medicine, V13, P119, DOI 10.1016/0736-4679(94)00121-9

[2] A RANDOMIZED CONTROLLED TRIAL OF INTRAVENOUS HALOPERIDOL VS. INTRAVENOUS METOCLOPRAMIDE FOR ACUTE MIGRAINE THERAPY IN THE EMERGENCY DEPARTMENT [J].

Gaffigan, Matthew E. ;

Bruner, David I. ;

Wason, Courtney ;

Pritchard, Amy ;

Frumkin, Kenneth .

JOURNAL OF EMERGENCY MEDICINE, 2015, 49 (03) :326-334